Search alternatives:
lines » line (Expand Search)
like » life (Expand Search)
Showing 461 - 480 results of 555 for search '(( greater decrease ) OR ((((( lines increase ) OR ( like decrease ))) OR ( peer decrease ))))*', query time: 0.16s Refine Results
  1. 461

    An Investigation into the factors influencing Arabic speaking students’ proficiency in the Arabic language in Dubai British School by AL AHMAD, ALAAEDDIN MEHY

    Published 2022
    “…The primary findings of the study are that while all the students’ proficiency was negatively influenced by the factor of language variation of the Arabic language, such an influence was felt more by the students in the British schools. This is likely due to the difference in linguistic environment experienced by the students in the British schools, relative to those in the Arabic schools, and which this study significantly correlated with decreased proficiency. …”
    Get full text
  2. 462

    Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 by Austin, Carter

    Published 2024
    “…HIV-related deaths decreased by 39·7% (33·7–44·5), from 1·19 million (1·07–1·37) in 2010 to 718 000 (669 000–785 000) in 2021. …”
    Get full text
    Get full text
    Get full text
    article
  3. 463

    Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Stud... by Robert C Reiner (5147636)

    Published 2020
    “…Findings The greatest declines in diarrhoeal mortality were seen in south and southeast Asia and South America, where 54·0% (95% uncertainty interval [UI] 38·1–65·8), 17·4% (7·7–28·4), and 59·5% (34·2–86·9) of units, respectively, recorded decreases in deaths from diarrhoea greater than 10%. …”
  4. 464

    Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 by Joseph L Ward (9715619)

    Published 2021
    “…Furthermore, indirect effects of the COVID-19 pandemic are likely to jeopardise efforts to improve health outcomes including mortality in young people aged 10–24 years. …”
  5. 465

    Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 by Hmwe Hmwe Kyu (8674014)

    Published 2022
    “…During the same period, LRI episodes and deaths in children younger than 15 years were estimated to have decreased, and the greatest decline was observed for LRI deaths in males younger than 5 years (–70·7% [–77·2 to –61·8]). …”
  6. 466

    Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 by Natalia V, Bhattacharjee

    Published 2024
    “…Additionally, the distribution of livebirths across the globe is shifting, with a greater proportion occurring in the lowest-income countries. …”
    Get full text
    Get full text
    Get full text
    article
  7. 467
  8. 468

    The Contribution of the UAE School Inspection Framework as a Quality Assurance Tool for School Transformation and Performance Improvement by EL SAADI, DINA HUSSEIN

    Published 2017
    “…It is recommended that American schools in Dubai must fine-tune global school transformation elements in line with school performance indicators so as to remain globally competitive in an increasingly globalized world.…”
    Get full text
  9. 469

    Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro by Najem, Sonia A.

    Published 2019
    “…Objective: In this study, we evaluated the effect of Suberoylanilide Hydroxamic Acid (SAHA), a panhistone deacetylase inhibitor, and Decitabine (DAC), a DNA methyltransferase inhibitor, either alone or in combination, on Caco-2 human colon cancer cell line in vitro. Results: Our results showed that SAHA and DAC, separately, significantly decreased cell proliferation, induced apoptosis and cell cycle arrest of Caco-2 cell line. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  10. 470

    Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer by El-Amm, Joelle

    Published 2017
    “…Abiraterone acetate has established a major role in the treatment paradigm of metastatic castration-resistant prostate cancer ever since pivotal trials, COU-AA-301 and COU-AA-302, have shown benefit in both the second-line and first-line (post- and pre-chemotherapy) setting, respectively, with improvement in overall survival as well as secondary end points such as prostate-specific antigen (PSA) and radiographic response rates, time to PSA progression, and progression-free survival. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  11. 471
  12. 472

    Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report by Maysaloun Merhi (4246147)

    Published 2018
    “…His NY-ESO-1 antibody was found to be lower after the third (****p < 0.0001) and the fifth (****p < 0.0001) cycles of treatment compared to base line, and this was in line with the stability of the disease. …”
  13. 473
  14. 474

    The changing landscape in the treatment of metastatic castration-resistant prostate cancer by El Amm, Joelle

    Published 2012
    “…The past few years have brought increasing advances in the therapeutic management of metastatic castration-resistant prostate cancer with the approval of several agents, including vaccine therapy with sipuleucel-T, second-line chemotherapy with cabazitaxel, the bone-targeted pharmaceutical denosumab, and the novel antiandrogen therapy abiraterone acetate. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  15. 475

    The Effect of HuArgI (Co)-PEG5000 on The Migration of Ovarian Cancer by El Mais, Nour

    Published 2020
    “…Finally, we looked at the effect of HuArgI (Co)-PEG5000 on 3D motility of the ovarian cancer cell line, using a collagen based assay. It showed that SKOV3 cell line does not show significant invasiveness to collagen. …”
    Get full text
    Get full text
    Get full text
    masterThesis
  16. 476

    Emerging therapies in multiple myeloma by El-Amm, Joelle

    Published 2015
    “…However, despite the increased effectiveness of the first-line agents, the majority of patients will eventually relapse and become drug resistant. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  17. 477
  18. 478

    Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors by Naila Rabbani (291722)

    Published 2022
    “…In the National Cancer Institute human tumor cell line screen, BBGD was most active against the glioblastoma SNB-19 cell line. …”
  19. 479

    PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer by Ghaneya Al-Khadairi (14153274)

    Published 2019
    “…Gene ontology analyses revealed enrichment of genes that are dysregulated in ovarian and esophageal cancer and are involved in transcription and apoptosis. In line with this, interrogation of TCGA and GTEx data demonstrated an increased PRAME expression in ovarian and esophageal tumor tissues in addition to breast tumors where it is associated with worse survival. …”
  20. 480

    Modeling and Performance Analysis of mmWave and WiFi-Based Vehicle Communications by Mohamed Rjab (21393908)

    Published 2024
    “…This study explores a comparative analysis of mmWave and WiFi transmission technologies, with a specific focus on line-of-sight (LoS) and non-line-of-sight (NLoS) scenarios in both 2D and 3D modeling environments. …”